Novation Holdings Inc. (NOHO)

[crossball]

According to Michael Gelmon, Chairman and CEO of ALZM: "The acquisition of the
OV-Watch technology will add another cutting-edge medical device technology to
the growing line up of Allezoe Medical subsidiaries. We are excited about the
potential of this acquisition and look forward to working with the OVWatch team
to build this product."

Closing of the merger is subject to the approval of a majority of the
shareholders of OVWatch, and also to the amendment of the Articles of
Incorporation of ALZM to increase the authorized shares and to implement a
reverse stock split of the common stock, the process for which will commence
within 5 days